Company intelligence / Profile preview

Edge BioInnovation Consulting and Management

Washington, District of Columbia, United Statespmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Preclinical

Overview

Edge BioInnovation Consulting and Management is an active consulting firm specializing in life sciences with expertise in antiviral therapies and vaccine development. The founder has been involved in high-level scientific advisory roles during the COVID-19 pandemic.

Therapeutic areas: Infectious Diseases
Modalities: Antiviral therapiesVaccines
Industry: Consulting

Partnerships

Participated in global collaborations for COVID‑19 vaccine efforts

Beyond the preview

Go deeper on Edge BioInnovation Consulting and Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Edge BioInnovation Consulting and Management.

Explore the full profile